FDA Inspection 1280205 — Creative Testing Solutions

Creative Testing Solutions — FEI 3000204058

The FDA completed an inspection of Creative Testing Solutions on Aug 29, 2025 in Tempe, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 29, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tempe, AZ (United States)

Citations

IDCFRDescription
1228821 CFR 1271.80(c)Manufacturer instructions not followed
9821 CFR 606.100(c)Thorough investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.